115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular monitoring with tumor DNA and nivolumab maintenance: A pilot study in diffuse large B-cell lymphoma
    Meeting Abstract

    Nakhoda, S.; Sklarz, T.; Pagan, C.; Matasar, M.; Messmer, M.; Frosch, Z. A. K.; Wang, Y. L.; Yanovsky, A. V.; Khanal, R.; Tan, C. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary MDS/AML that develops after acquired aplastic anemia
    Meeting Abstract

    Connor, M. P.; Prathapa, N.; Frey, N. V.; Gill, S.; Hexner, E. O.; Bruno, X. J.; Lai, C.; Loren, A. W.; Luger, S. M.; Matthews, A. H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Physician treatment preferences in relapsed/refractory follicular lymphoma: A discrete choice experiment
    Meeting Abstract

    Gribben, J. G.; Bachy, E.; Ray, M.; Krupsky, K.; Beusterien, K.; Kopenhafer, L.; Mendez, F.; Beygi, S.; Best, T.; Ball, G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ivosidenib for patients with clonal cytopenia of undetermined significance and mutations in IDH1
    Meeting Abstract

    Petrone, G.; Stein, E. M.; Bolton, K. L.
    Blood (2023)

    Fulltext@MSK | Save
  • High risk of GvHD in children transplanted for refractory cytopenia of childhood: Importance of sufficient exposure to anti-thymocyte globulin
    Meeting Abstract

    Koopman-Coenen, E.; Meesters-Ensing, J.; Nierkens, S.; Kal, I. J.; Müskens, K. F.; Versluijs, B.; Lindemans, C. A.; Harris, A. C.; Bierings, M.; Admiraal, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in patients with JAK inhibitor-naive myelofibrosis and moderate thrombocytopenia (XPORT-MF-044)
    Meeting Abstract

    Scandura, J. M.; Gerds, A. T.; Ritchie, E. K.; Wang, X.; Kye, S.; Rampal, R. K.
    Blood (2023)

    Fulltext@MSK | Save
  • Multi-cancer early detection test is sensitive and accurate in detecting shared DNA methylation signal in a variety of lymphoid and plasma cell neoplasms
    Meeting Abstract

    Westgate, C.; Salles, G.; Shih, S.; Lopatin, M.; Kurtzman, K. N.; Kappes, K.; Venn, O.; Parekh, S.; Venstrom, J. M.; Younes, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • An updated comparison of clinical outcomes from 4-year follow-up of ZUMA-5 (axicabtagene ciloleucel) and the international scholar-5 external control cohort in relapsed/refractory follicular lymphoma
    Meeting Abstract

    Gribben, J. G.; Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Antigen-specific t-cell repertoire responses following COVID-19 vaccination are intact in majority of patients with B-cell lymphoid malignancies on active therapy
    Meeting Abstract

    Goel, S.; Griffiths, E. A.; Segal, B.; Nemeth, M.; Cortese, M. J.; Hernandez-Ilizaliturri, F. J.; Banbury, B.; Schumacher, E.; Torka, P.; Ghione, P.
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamic changes in lymph node size and skin scoring predict response to treatment in CTCL: An interim analysis
    Meeting Abstract

    Fahmy, L. M.; Yang, H. R.; Zhou, M.; Beylergil, V.; Schreidah, C. M.; Bilgrami, Z.; Kwinta, B. D.; Schwartz, L.; Fojo, A. T.; Bates, S. E.; more...
    Blood (2023)

    Fulltext@MSK | Save